- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/92 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol
Patent holdings for IPC class G01N 33/92
Total number of patents in this class: 1926
10-year publication summary
159
|
206
|
188
|
198
|
169
|
166
|
131
|
142
|
119
|
32
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Zora Biosciences Oy | 45 |
40 |
The Regents of the University of California | 18943 |
35 |
Denka Company Limited | 2189 |
33 |
Micromass UK Limited | 1121 |
33 |
Quest Diagnostics Investments Incorporated | 432 |
24 |
Labrador Diagnostics LLC | 287 |
21 |
Denka Seiken Co., Ltd. | 95 |
18 |
Polymer Technology Systems, Inc. | 169 |
17 |
President and Fellows of Harvard College | 5792 |
16 |
LipoScience, Inc. | 66 |
16 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
15 |
Kyowa Medex Co., Ltd. | 102 |
15 |
The Regents of the University of Colorado, a body corporate | 2430 |
14 |
F. Hoffmann-La Roche AG | 7958 |
13 |
Duke University | 2872 |
13 |
The Brigham and Women's Hospital, Inc. | 2087 |
13 |
The Cleveland Clinic Foundation | 1591 |
12 |
Sysmex Corporation | 1418 |
12 |
Purdue Research Foundation | 3277 |
10 |
Waters Technologies Corporation | 1654 |
10 |
Other owners | 1546 |